6.
Kummer J, Kamp A, Citarella F, Horrevoets A, Hack C
. Expression of human recombinant granzyme A zymogen and its activation by the cysteine proteinase cathepsin C. J Biol Chem. 1996; 271(16):9281-6.
DOI: 10.1074/jbc.271.16.9281.
View
7.
Oliveira J, Karrar S, Rainbow D, Pinder C, Clarke P, Rubio Garcia A
. The plasma biomarker soluble SIGLEC-1 is associated with the type I interferon transcriptional signature, ethnic background and renal disease in systemic lupus erythematosus. Arthritis Res Ther. 2018; 20(1):152.
PMC: 6062988.
DOI: 10.1186/s13075-018-1649-1.
View
8.
Dominguez-Aleman C, Sanchez-Vargas L, Hernandez-Flores K, Torres-Zugaide A, Reyes-Sandoval A, Cedillo-Barron L
. Dengue Virus Induces the Expression and Release of Endocan from Endothelial Cells by an NS1-TLR4-Dependent Mechanism. Microorganisms. 2021; 9(6).
PMC: 8232724.
DOI: 10.3390/microorganisms9061305.
View
9.
Vejchapipat P, Theamboonlers A, Chongsrisawat V, Poovorawan Y
. An evidence of intestinal mucosal injury in dengue infection. Southeast Asian J Trop Med Public Health. 2006; 37(1):79-82.
View
10.
Braun E, Hotter D, Koepke L, Zech F, Gross R, Sparrer K
. Guanylate-Binding Proteins 2 and 5 Exert Broad Antiviral Activity by Inhibiting Furin-Mediated Processing of Viral Envelope Proteins. Cell Rep. 2019; 27(7):2092-2104.e10.
DOI: 10.1016/j.celrep.2019.04.063.
View
11.
Fink J, Gu F, Ling L, Tolfvenstam T, Olfat F, Chin K
. Host gene expression profiling of dengue virus infection in cell lines and patients. PLoS Negl Trop Dis. 2007; 1(2):e86.
PMC: 2100376.
DOI: 10.1371/journal.pntd.0000086.
View
12.
Huang J, Liang W, Chen S, Zhu Y, Chen H, Mok C
. Serum Cytokine Profiles in Patients with Dengue Fever at the Acute Infection Phase. Dis Markers. 2018; 2018:8403937.
PMC: 5831957.
DOI: 10.1155/2018/8403937.
View
13.
van de Weg C, van den Ham H, Bijl M, Anfasa F, Zaaraoui-Boutahar F, Dewi B
. Time since onset of disease and individual clinical markers associate with transcriptional changes in uncomplicated dengue. PLoS Negl Trop Dis. 2015; 9(3):e0003522.
PMC: 4358925.
DOI: 10.1371/journal.pntd.0003522.
View
14.
Derksen P, Keehnen R, Evers L, van Oers M, Spaargaren M, Pals S
. Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma. Blood. 2002; 99(4):1405-10.
DOI: 10.1182/blood.v99.4.1405.
View
15.
Foss S, Bottermann M, Jonsson A, Sandlie I, James L, Andersen J
. TRIM21-From Intracellular Immunity to Therapy. Front Immunol. 2019; 10:2049.
PMC: 6722209.
DOI: 10.3389/fimmu.2019.02049.
View
16.
Nikolayeva I, Bost P, Casademont I, Duong V, Koeth F, Prot M
. A Blood RNA Signature Detecting Severe Disease in Young Dengue Patients at Hospital Arrival. J Infect Dis. 2018; 217(11):1690-1698.
PMC: 5946912.
DOI: 10.1093/infdis/jiy086.
View
17.
Zulkipli M, Rampal S, Bulgiba A, Peramalah D, Jamil N, See L
. Is there any association between body mass index and severity of dengue infection?. Trans R Soc Trop Med Hyg. 2021; 115(7):764-771.
DOI: 10.1093/trstmh/trab021.
View
18.
Suwarto S, Sasmono R, Sinto R, Ibrahim E, Suryamin M
. Association of Endothelial Glycocalyx and Tight and Adherens Junctions With Severity of Plasma Leakage in Dengue Infection. J Infect Dis. 2017; 215(6):992-999.
PMC: 5407050.
DOI: 10.1093/infdis/jix041.
View
19.
Quintino-de-Carvalho I, Goncalves-Pereira M, Faria Ramos M, de Aguiar Milhim B, Da Costa U, Santos E
. Type 1 Innate Lymphoid Cell and Natural Killer Cells Are Sources of Interferon-γ and Other Inflammatory Cytokines Associated With Distinct Clinical Presentation in Early Dengue Infection. J Infect Dis. 2021; 225(1):84-93.
DOI: 10.1093/infdis/jiab312.
View
20.
Malavige G, Jeewandara C, Ogg G
. Dysfunctional Innate Immune Responses and Severe Dengue. Front Cell Infect Microbiol. 2020; 10:590004.
PMC: 7644808.
DOI: 10.3389/fcimb.2020.590004.
View